Clinical Trial Update: A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HR17031 with insulin glargine in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HR17031
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Adult Patients With Type 2 Diabetes | Phase 3 | Status: COMPLETED